https://pubmed.ncbi.nlm.nih.gov/40083427/
Eliglustat substrate reduction therapy in children with Gaucher disease type 1
Eliglustat demonstrated significant clinical benefits in pediatric GD1 patients, as evidenced by reductions in GlcSph levels and other disease indicators. The...
in childrengaucher diseaseeliglustatsubstratereduction
https://www.semanticscholar.org/topic/eliglustat-tartrate/2022472
eliglustat tartrate | Semantic Scholar
eliglustatsemanticscholar